Product Information

ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0333 per EA under NDC 57237016805. Its NADAC has been published 511 times since Nov 9, 2016.

FDA first approved this application on Jul 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROSUVASTATIN CALCIUM 5 MG TAB

Rosuvastatin Calcium
$0.0333per EA

Strength

5 mg/1

NDC

57237016805

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA079170

FDA Approved

7/19/2016

TE Code

AB

On Market Since

7/19/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 511 times since Nov 9, 2016, and over the history we have for it it has declined 91.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0333 per EA
All-time high$0.3752 (Nov 16, 2016)
All-time low$0.0333 (Aug 19, 2026)
52-week high$0.0389
52-week low$0.0333
Median price$0.0724
Average price$0.0833
Largest weekly change-24.9% (Jan 18, 2017)
Weeks tracked511
Tracking sinceNov 9, 2016

Price History

1W

-2.0%

1M

-2.0%

3M

-4.7%

6M

-2.5%

1Y

-14.5%

3Y

-32.2%

5Y

-59.8%

All

-91.1%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.0333 per EA (NDC 57237016805), effective Aug 19, 2026.

How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 91.1%. It has been tracked across 511 weekly CMS publications since Nov 9, 2016.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?

Since Nov 9, 2016, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0333 (Aug 19, 2026) to a high of $0.3752 (Nov 16, 2016), with a median of $0.0724 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?

ROSUVASTATIN CALCIUM 5 MG TAB (NDC 57237016805) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.